<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0"><channel><title>Individual feed for https://www.medscape.com/cx/rssfeeds/2700.xml</title><link>https://www.medscape.com/cx/rssfeeds/2700.xml</link><description>Individual feed output.</description><lastBuildDate>Mon, 30 Jun 2025 14:52:17 GMT</lastBuildDate><generator>PyRSS2Gen-1.1.0</generator><docs>http://blogs.law.harvard.edu/tech/rss</docs><item><title>FDA Approves First Treatment for MAS in Still Disease</title><link>https://www.medscape.com/viewarticle/fda-approves-first-treatment-macrophage-activation-syndrome-2025a1000hfv?src=rss</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture9.png</image_url><description>Emapalumab is approved for both adults and pediatric (newborn and older) patients with MAS in Still disease with an inadequate response or intolerance...</description><pubDate>Mon, 30 Jun 2025 18:42:01 GMT</pubDate></item><item><title>FDA Drops REMS Programs for Some CAR-Ts</title><link>https://www.medscape.com/viewarticle/fda-drops-rems-programs-some-car-ts-2025a1000hfn?src=rss</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture3.png</image_url><description>Using CAR T-cell therapies for blood cancer should be less burdensome following labeling updates. Medscape Medical News</description><pubDate>Mon, 30 Jun 2025 17:21:53 GMT</pubDate></item><item><title>Novel Drug Lowers Stubbornly High BP in Phase 3 Trial</title><link>https://www.medscape.com/viewarticle/novel-drug-lowers-stubbornly-high-bp-phase-3-trial-2025a1000hei?src=rss</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture4.png</image_url><description>Lorundrostat, an aldosterone synthase inhibitor, effectively treated uncontrolled hypertension in Launch-HTN, researchers reported in JAMA. Medscape M...</description><pubDate>Mon, 30 Jun 2025 16:05:00 GMT</pubDate></item><item><title>New AI System to Flag NHS Safety Risks Early</title><link>https://www.medscape.com/viewarticle/new-ai-system-flag-nhs-safety-risks-early-2025a1000hes?src=rss</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture8.png</image_url><description>The UK will deploy AI technology to scan NHS data in real time, aiming to detect safety issues faster and prevent patient harm. Medscape News UK</description><pubDate>Mon, 30 Jun 2025 14:31:53 GMT</pubDate></item><item><title>Revascularizing Vessels After STEMI Sees Durable Gains</title><link>https://www.medscape.com/viewarticle/benefits-last-10-years-revascularization-non-culprit-vessels-2025a1000heo?src=rss</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture2.png</image_url><description>Revascularization of all vessels with stenosis was linked to lower rates of death, another MI, and further revascularization in a 10-year follow-up st...</description><pubDate>Mon, 30 Jun 2025 13:28:37 GMT</pubDate></item></channel></rss>